We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and drive inventive Life Sciences start-ups to success.
We embrace French Life Sciences’ dynamic of innovation. France harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. Adbio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring France’s biotechnology ecosystem. With
Adbio partners was founded in 2015 and is AMF regulated since 2016.
Overview
Portfolio 3
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| May 10, 2023 | DiogenX | diogenx.com | $35.2M | France, Provence-Alpes-Côte d'Azur, Marseille |
| May 3, 2023 | ARTHEx Biotech | arthexbiotech.com | $138.32M | Spain |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 18, 2023 | Orikine Bio cierra una ronda Seed de €5,5M con Sabadell Asabys y AdBio | 18/07/2023 Nota de prensa ORIKINE BIO CIERRA UNA RONDA SEED DE €5,5M CON SABADELL ASABYS Y ADBIO Orikine Bio, compañía de biotecnología que desarrolla una nueva plataforma propia de terapias basadas en citoquinas para enfermedades autoin... |
| Jun 19, 2023 | Anoat Therapeutics Raises €2M in Seed Funding | Anoat Therapeutics, a Paris, France-based preclinical stage biotechnology company specialized in Cystic Fibrosis (CF), raised €2M in Seed funding. The round was led by AdBio partners, a venture capital company specialized in seed investment... |
| May 11, 2023 | Biotech startup DiogenX secures €27.5M to develop therapeutic solutions for Type 1 diabetes | Marseille-based DiogenX, a preclinical-stage biotech company specialising in the development of pancreatic beta-cell modulators for the treatment of diabetes, announced on Wednesday, May 10, that it has raised €27.5M in a Series A round of ... |
| May 4, 2023 | ARTHEx Biotech announces Closing of €42M Series B round led by Columbus. EIC), Hadean, Sound Bioventures, Invivo, AdBio and CDTI also participated | 04/05/2023 Nota de prensa ARTHEX BIOTECH ANNOUNCES CLOSING OF €42M SERIES B ROUND LED BY COLUMBUS. EIC), HADEAN, SOUND BIOVENTURES, INVIVO, ADBIO AND CDTI ALSO PARTICIPATED ARTHEx Biotech S.L., a clinical-stage biotechnology company focu... |
| Sep 16, 2022 | French biotech Tridek-One gets €16 million booster to restore the immune balance in patients | Paris-based biotech startup Tridek-One has raised €16 million in funding to speed up its research and development of CD31 agonists to restore the immune balance. The round was led by the Swiss VC Pureos Bioventures with the participation of... |
Reviews 0
FAQ about AdBio Partners
When was AdBio Partners founded?
AdBio Partners was founded in 2015.
How many startups has AdBio Partners invested in?
AdBio Partners has 3 portfolio companies on Parsers VC, among them DiogenX and ARTHEx Biotech.
What has the press written about AdBio Partners?
Parsers VC has collected 6 articles mentioning AdBio Partners, among them “Orikine Bio cierra una ronda Seed de €5,5M con Sabadell Asabys y AdBio” (Jul 18, 2023) and “Anoat Therapeutics Raises €2M in Seed Funding” (Jun 19, 2023).
Is AdBio Partners still active?
Yes, AdBio Partners is active; its latest activity on Parsers VC dates from Jul 7, 2025.